Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma

BACKGROUND: Triple-negative breast cancers (TNBCs) lack the estrogen, progesterone, and epidermal growth factor (EGF) receptor-2 (HER2/neu) receptors. Patients with TNBC have typical high grading, more frequent relapses, and exhibit poorer outcomes or prognosis compared with the other subtypes of br...

Descripción completa

Detalles Bibliográficos
Autores principales: Haxho, Fiona, Allison, Stephanie, Alghamdi, Farah, Brodhagen, Lacey, Kuta, Victoria EL, Abdulkhalek, Samar, Neufeld, Ronald J, Szewczuk, Myron R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266271/
https://www.ncbi.nlm.nih.gov/pubmed/25525387
http://dx.doi.org/10.2147/BCTT.S74663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266271/
https://www.ncbi.nlm.nih.gov/pubmed/25525387
http://dx.doi.org/10.2147/BCTT.S74663

Ejemplares similares